Underutilization of primary care and receipt of preventive health services have been reported among women with opioid use disorder. The aim of this study was to describe perceptions of primary care among women in treatment for opioid use disorder.
Methods:
Between May and June 2022, 27 women who were receiving treatment for opioid use disorder from one opioid treatment program participated in this study. Participants completed one data collection session which involved a brief questionnaire followed by a semi-structured interview. Participants were asked questions about their overall experience with primary care as well as perceived facilitators and barriers to primary care utilization and quality. Interview transcripts were analyzed using an inductive thematic approach.
Results:
Three themes emerged from the interviews within the domain of “Facilitators to Primary Care,” including: (1) coordination of care, (2) continuity of care, and (3) relationship with health care providers. Four themes emerged from the interviews within the domain of “Barriers to Primary Care,” including: (1) perceived judgment from health care providers, (2) childcare needs, (3) issues related to location, and (4) issues related to time.
Conclusion:
Approaches to primary care that help alleviate barriers to care and highlight the aspects of care that are valued may improve quality and utilization of care, thus enhancing the health and well-being of a vulnerable population.
FriedbergMWHusseyPSSchneiderEC.Primary care: a critical review of the evidence on quality and costs of health care. Health Affairs. 2010;29(5):766-772.
AndersonKEAlexanderGCNilesLScholleSHSalonerBDySM.Quality of preventive and chronic illness care for insured adults with opioid use disorder. JAMA Netw Open. 2021;4(4):e214925.
4.
Benjamin-JohnsonRMooreAGilmoreJ, et al. Access to medical care, use of preventive services, and chronic conditions among adults in substance abuse treatment. Psychiatr Serv. 2009;60(12):1676-1679.
5.
KendallCEBoucherLMDonelleJ, et al. Engagement in primary health care among marginalized people who use drugs in Ottawa, Canada. BMC Health Serv Res. 2020;20(1):837.
6.
ShortVLHandDJPyferL, et al. Health status and preventive health services among reproductive-aged women in treatment for opioid use disorder. Womens Health Rep (New Rochelle). 2022;3(1):998-1005.
7.
HeilSJonesHEArriaA, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40:199-202.
8.
KotelchuckMChengERBelanoffC, et al. The prevalence and impact of substance use disorder and treatment on maternal obstetric experiences and birth outcomes among singleton deliveries in Massachusetts. Matern Child Health J. 2017;21(4):893-902.
9.
SchempfAHStrobinoDM.Illicit drug use and adverse birth outcomes: is it drugs or context?J Urban Health. 2008;85(6):858-873.
10.
AlmarioCVSeligmanNSDysartKCBerghellaVBaxterJK.Risk factors for preterm birth among opiate-addicted gravid women in a methadone treatment program. Am J Obstet Gynecol. 2009;201:326.e1-326.e6.
11.
HolbrookAMBaxterJKJonesHE, et al. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine. Addiction. 2012;107(Suppl 1):83-90.
12.
JonesHEHeilSHO’GradyKE, et al. Smoking in pregnant women screened for an opioid agonist medication study compared to related pregnant and non-pregnant patient samples. Am J Drug Alcohol Abuse. 2009;35:375-380.
13.
TerplanMHandDJHutchinsonMSalisbury-AfsharEHeilSH.Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review. Prev Med. 2015;80:23-31.
14.
ViscontiAJSellJGreenblattAD.Primary care for persons who inject drugs. Am Fam Physician. 2019;99(2):109-116.
15.
HaddadMSZelenevAAlticeFL.Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers. J Urban Health. 2015;92(1):193-213.
16.
SpithoffSKiranTKhuuW, et al. Quality of primary care among individuals receiving treatment for opioid use disorder. Can Fam Physician. 2019;65(5):343-351.
17.
AlexanderKShortVGannonMGoyalNNaegleMAbatemarcoDJ.Identified gaps and opportunities in perinatal healthcare delivery for women in treatment for opioid use disorder. Substance Abuse. 2021;42(4):552-558.
18.
ShortVAlexanderKGannonMAbatemarcoDGoyalN.What aspects of their child’s primary care do mothers value? A qualitative analysis of perspectives of women in treatment for opioid use disorder. Child Care Health Dev. 2021;47(1):40-46.
19.
ShortVGannonMSoodE, et al. Opportunities to increase well child care engagement for families affected by maternal opioid use disorder: perceptions of mothers and clinicians. Acad Pediatr. 2023;23(2):425-433.
20.
ShortVGoyalNChungEHandDAbatemarcoD.Perceptions of pediatric primary care among mothers in treatment for opioid use disorder. J Commun Health. 2019;44(6):1127-1134.
21.
MacAfeeLKHarfmannRFCannonLM, et al. Substance use treatment patient and provider perspectives on accessing sexual and reproductive health services: barriers, facilitators, and the need for integration of care. Subst Use Misuse. 2020;55(1):95-107.
22.
HenninkMKaiserBN.Sample sizes for saturation in qualitative research: a systematic review of empirical tests. Soc Sci Med. 2022;292:114523.
23.
HarrisPATaylorRThielkeR, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
TongASainsburyPCraigJ.Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-357.
26.
Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press; 2001.
27.
StewartMBrownJBDonnerA, et al. The impact of patient centered care on outcomes. J Fam Pract. 2000;49(9):796-804.
28.
McMillanSSKendallESavA, et al. Patient-centered approaches to health care: a systematic review of randomized controlled trials. Med Care Res Rev. 2013;70(6):567-596.
29.
FiellinDAO’ConnorPGChawarskiM, et al. Methadone maintenance in primary care: a randomized controlled trial. JAMA. 2001;286:1724-1731.
30.
FoxADMasyukovaMCunninghamCO.Optimizing psychosocial support during office-based buprenorphine treatment in primary care: patients’ experiences and preferences. Subst Abus. 2016;37:70-75.
31.
JonesCMByrdDJClarkeTJ, et al. Characteristics and current clinical practices of opioid treatment programs in the United States. Drug Alcohol Depend. 2019;205:107616.
32.
GoodmanD.Improving access to maternity care for women with opioid use disorders: colocation of midwifery services at an addiction treatment program. J Midwifery Womens Health. 2015;60(6):706-712.
33.
ShortVLHandDMancusoF, et al. Group prenatal care for pregnant women with opioid use disorder: preliminary evidence for acceptability and benefits compared to individual prenatal care. Birth2024;51(1):144-151.
34.
GoyalNGannonMSoodE, et al. Group well child care for mothers with opioid use disorder: framework for implementation. Matern Child Health J. 2023;27:75-86.
